Joe von Rickenbach
Joe von Rickenbach is a Senior Advisor at General Atlantic, providing strategic support and advice to the firm’s investment teams and portfolio companies in the Life Sciences sector. Joe is also currently the Managing Director of stet vision LLC. Prior to that, he was Co-Founder, President, and CEO of biotechnology company Helio Vision, Inc., a Boston-based ophthalmic biopharma company developing a therapy for proliferative vitreoretinopathy which was merged with Aldeyra, Inc. (NASDAQ: ALDX) in 2019. Joe was also the Co-Founder, Chairman, and CEO of PAREXEL International Corporation, leading the company in its growth from one of the first clinical research organizations in the early 1980s to its place as a leading global biopharmaceutical services provider, including its IPO, multiple secondary offerings, and over 40 mergers & acquisitions during his 36-year tenure. After beginning his career with Schering-Plough, he held positions with ENSECO (formerly ERCO).
Joe was named Executive of the Year in North America in the 2010 International Business Awards and won the Ernst & Young New England Entrepreneur of the Year Award in 1997. In 2013, he was honored by the Massachusetts Biotechnology Council with the Henri Termeer Innovative Leadership Award. In 2014, he was named Immigrant Entrepreneur of the Year in Life Sciences. In 2018, he received the Scrip Informa Lifetime Achievement Award and was awarded the Ellis Island Medal of Honor.
Current Board Affiliations
Senior Advisors are independent contractors that are advisors to General Atlantic and its portfolio companies. They are not employees nor affiliates of General Atlantic entities.
Advisory Directors are former Managing Directors who have retired under General Atlantic’s retirement policy.